Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: Emphasis on a global evaluation and recognition of diagnostic pitfalls

Leukemia Research

Volumn 32, Issue 2, 2008, Pages 215-224

  Stachurski, Dariusz ^a   Smith, Brian R ^b   Pozdnyakova, Olga ^a   Andersen, Mary ^a   Xiao, Zhefu ^a   Raza, Azra ^a   Woda, Bruce A ^a   Wang, Sa A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Flow cytometry; Myelodysplasia; Myeloproliferative disorders

Indexed keywords

ARTICLE; BONE MARROW DISEASE; CELL MATURATION; CELL POPULATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MONOCYTE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL;

ANTIGENS, CD; BONE MARROW CELLS; BONE MARROW DISEASES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MONOCYTES; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 38949208415     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.06.012     Document Type: Article

References (30)

1. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
2. Bruming R.D., Matutes E., Harris N.L., et al. Acute myeloid leukaemia. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon 77-80
3. Kuroda J., Kimura S., Kobayashi Y., et al. Unusual myelodysplastic syndrome with the initial presentation mimicking idiopathic thrombocytopenic purpura. Acta Haematol 108 (2002) 139-143
4. Steensma D.P., Dewald G.W., Hodnefield J.M., et al. Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?. Leuk Res 27 (2003) 235-242
5. Schmitt-Graeff A., Mattern D., Kohler H., et al. Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis. Pathologe 21 1 (2000) 1-15
6. Sole F., Espinet B., Sanz G.F., et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. Br J Haematol 108 2 (2000) 346-356
7. Bowen K.L., and Davis B.H. Abnormal patterns of expression of CD16 (FcR-III) and CD11b (CRIII) in the bone marrow of patients with myelodysplastic syndrome. Lab Hematol 3 (1997) 292-298
8. Hansen I., Meyer K., and Hokland P. Flow cytometric identification of myeloid disorders by asynchronous expression of the CD14 and CD66 antigens. Eur J Haematol 61 (1998) 339-346
9. Chang C.C., and Cleveland R.P. Decreased CD10-positive mature granulocytes in bone marrow from patients with myelodysplastic syndrome. Arch Pathol Lab Med 124 (2000) 1152-1156
10. Ohsaka A., Saionji K., Igari J., et al. Altered surface expression of effector cell molecules on neutrophils in myelodysplastic syndromes. Br J Haematol 98 (1997) 108-113
11. Otawa M., Kawanishi Y., Iwase O., et al. Comparative multicolor flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia. Leuk Res 24 (2000) 359-366
12. Mann K.P., DeCastro C.M., Liu J., et al. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes. Am J Clin Pathol 107 (1997) 653-660
13. Ogata K., Nakamura K., Yokose N., et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 100 12 (2002) 3887-3896
14. Maynadie M., Picard F., Husson B., et al. Groupe d'Etude Immunologique des Leucemies (GEIL). Immunophenotypic clustering of myelodysplastic syndromes. Blood 100 7 (2002) 2349-2356
15. Ogata K., Kishikawa Y., Satoh C., et al. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 108 3 (2006) 1037-1044
16. Monreal M.B., Pardo M.L., Pavlovsky M.A., et al. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia. Cytometry B Clin Cytom 70 2 (2006) 63-70
17. Malcovati L., Della Porta M.G., Lunghi M., et al. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia 19 5 (2005) 776-783
18. Della Porta M.G., Malcovati L., Invernizzi R., et al. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 20 4 (2006) 549-555
19. Schlesinger M., Silverman L.R., Jiang J.D., et al. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. J Clin Lab Immunol 48 (1996) 149-166
20. Xu D., Schultz C., Akker Y., et al. Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia. Am J Hematol 74 (2003) 9-16
21. Stetler-Stevenson M., Arthur D.C., Jabbour N., et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 98 (2001) 979-987
22. Kussick S.J., and Wood B.L. Using 4-color flow cytometry to identify abnormal myeloid populations. Arch Pathol Lab Med 127 (2003) 1140-1147
23. Wells D.A., Benesch M., Loken M.R., et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 102 (2003) 394-403
24. Wood B.L. Flow cytometric diagnosis of myelodysplasia and myeloproliferative disorders. J Biol Regul Homeost Agents 18 (2004) 141-145
25. Kussick S.J., Fromm J.R., Rossini A., et al. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol 124 2 (2005) 170-181
26. Mitelman F. An International System for Human Cytogenetic Nomenclature (ISCN) (1995), S. Karger, Basel
27. Fleitt H.B., Wright S.D., Durie C.J., et al. Ontogony of Fc receptors and complement receptor (CR3) during human myeloid differentiation. J Clin Invest 73 (1984) 516-525
28. Kussick S.J., and Wood B.L. Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders. Am J Clin Pathol 120 6 (2003) 854-865
29. Raptis A., Clave E., Mavroudis D., et al. Polymorphism in CD33 and CD34 genes: a source of minor histocompatibility antigens on haemopoietic progenitor cells?. Br J Haematol 102 5 (1998) 1354-1358
30. de Haas M., Kleijer M., van Zwieten R., Roos D., and von dem Borne A. Neutrophil FcR?IIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 86 (1995) 2403-2413